The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention.
about
Venous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer AnticoagulantsVenous thromboembolism following hematopoietic stem cell transplantation-a systematic review and meta-analysis.Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilization.Platelet transfusions for patients with haematological malignancies: who needs them?Clinical challenges in patients with cancer-associated thrombosis: Canadian expert consensus recommendationsIncidence and risk factors for life-threatening bleeding after allogeneic stem cell transplant.Clinical practice of platelet transfusions in haemato-oncology.Venous thromboembolism in hematopoietic stem cell transplant recipients.Variability in management of hematologic malignancy patients with venous thromboembolism and chemotherapy-induced thrombocytopeniaVenous thromboembolism in patients with hematologic malignancy and thrombocytopenia.Controversies in the management of cancer-associated thrombosis.Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort.Antithrombotic therapy and platelet transfusions in hematologic malignancy patients presenting chemotherapy-induced thrombocytopenia: a French survey.Venous thromboembolism prophylaxis in hematopoietic stem cell transplantation patients: an international web-based survey of healthcare providers.Cancer-associated thrombosis: an overviewHormone Use for Therapeutic Amenorrhea and Contraception During Hematopoietic Cell TransplantationAnalysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipientsVenous thromboembolism is associated with graft-versus-host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantationImpact of operative length on post-operative complications in meningioma surgery: a NSQIP analysis.Reduced IL-35 levels are associated with increased platelet aggregation and activation in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Acute myocardial infarction caused by filgrastim: a case report.Patients treated for acute VTE during periods of treatment-related thrombocytopenia have high rates of recurrent thrombosis and transfusion-related adverse outcomes.Laboratory biomarkers for venous thromboembolism risk in patients with hematologic malignancies: A review.Incidence of and risk factors for persistent gram-positive bacteraemia and catheter-related thrombosis in haematopoietic stem cell transplantation.
P2860
Q26741697-2240A7C0-E71F-45E4-AD33-43694F97A1A5Q30251535-F533AF72-AC97-4ECD-81D5-BA6BC9D4B827Q33389390-14B2597F-9779-4353-9FC0-BCDC3BC90874Q33395509-C54F976B-B2D0-4078-9590-7F1B9C0AE796Q33420469-C363AF97-BCE8-4225-91DB-03AD1E4B35AEQ33421514-825650C2-E5E9-485F-AB31-994FB310514CQ33421666-6FDD38B9-679C-4B7A-ACC8-DD926301E149Q33428591-4F7F88C5-E034-4ADA-9069-75B2774AFF11Q33430868-4C05AD0D-6F12-4EDA-A0E6-3A4E49AD478CQ33434346-F5658F8F-6C63-45E4-97E4-C8CBF01AE85CQ33436975-82EC8F60-0F07-4F80-9CB9-F7BD3DFE9961Q33440816-E8B2A452-61B9-4A15-AE78-C5399E517A60Q33441333-F7339263-2EA4-4170-A42F-28E7E2EE52E6Q33862707-6B494346-550D-49FE-BA57-BD3B29B210ACQ34655217-D05C58E7-00B0-485A-AA6F-5B0DDC9315C5Q36087035-DC462853-8BA6-4E1C-9C07-CD23681C85DCQ36862372-9585D0EF-517E-4587-A066-12812947CBB2Q38877336-89B14031-A5BC-4D2F-A11A-0766BF89E21EQ40444582-47067B99-F296-40BC-9D11-796249AF484CQ41685216-F0DAEFC9-BE71-4FF5-889A-D9E3D419DEA4Q42130863-E9C93658-6AEC-4571-A5CE-C4EFB6B2401AQ48015781-34C06864-82DB-467D-8B27-E6B921781B50Q50174496-2CCC8057-4FAC-4ADC-A952-8BC769BE2E11Q51145685-0D9AA723-2AA2-44E5-9387-88C16DF22838
P2860
The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
The incidence of and risk fact ...... plications for VTE prevention.
@en
The incidence of and risk factors for venous thromboembolism
@nl
type
label
The incidence of and risk fact ...... plications for VTE prevention.
@en
The incidence of and risk factors for venous thromboembolism
@nl
prefLabel
The incidence of and risk fact ...... plications for VTE prevention.
@en
The incidence of and risk factors for venous thromboembolism
@nl
P2093
P1433
P1476
The incidence of and risk fact ...... mplications for VTE prevention
@en
P2093
Jodi B Segal
Joyce Kane
M Yair Levy
Michael B Streiff
Richard J Jones
P304
P356
10.1182/BLOOD-2007-10-117051
P407
P577
2008-05-14T00:00:00Z